A new scientific first through use of human embryonic stem cells

For the first time, through the use of human embryonic stem cells (hES) sourced from pre-implantation diagnosis, researchers from Inserm’s Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I-Stem) have successfully identified the previously unknown mechanisms involved in Steinert’ disease, also known as type 1 myotonic dystrophy. This work was published on 31 March2011 inthe journal Cell Stem Cell and has been financed, in particular, through donations to Telethon.

 

<< Return to the section “Press releases”